HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway

Background Lung adenocarcinoma is one of the most common tumors, and cisplatin is frequently used in treating lung adenocarcinoma patients. This study aimed to look into the roles and mechanisms of HNF4G in cisplatin resistance of lung adenocarcinoma. Materials & Methods Cisplatin resistance and...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Jiaqi Liang, Guangyin Zhao, Yunyi Bian, Guoshu Bi, Qihai Sui, Huan Zhang, Haochun Shi, Guangyao Shan, Yiwei Huang, Zhencong Chen, Lin Wang, Cheng Zhan
Format: Artykuł
Język:English
Wydane: PeerJ Inc. 2023-03-01
Seria:PeerJ
Hasła przedmiotowe:
Lung adenocarcinoma
Cisplatin
HNF4G
MAPK6
Transcription factor
Dostęp online:https://peerj.com/articles/14996.pdf

Internet

https://peerj.com/articles/14996.pdf

Podobne zapisy